Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report.

Pujol-Gimenez J, de Heredia FP, Idoate MA, Airley R, Lostao MP, Evans AR.

J Cancer. 2015 Jan 5;6(2):139-43. doi: 10.7150/jca.10429. eCollection 2015.

2.

Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression.

Airley RE, McHugh P, Evans AR, Harris B, Winchester L, Buffa FM, Al-Tameemi W, Leek R, Harris AL.

Br J Cancer. 2014 Feb 4;110(3):715-23. doi: 10.1038/bjc.2013.765. Epub 2013 Dec 24.

3.

How the science of personalized medicines will change the clinical management of patients in the pharmacy.

Airley R, Evans A.

Future Med Chem. 2012 Oct;4(16):2023-7. doi: 10.4155/fmc.12.129. No abstract available.

PMID:
23157235
4.

Lab reports and cat scans: can veterinary oncology guide our way to new treatments for human cancers?

Airley R.

Future Med Chem. 2012 Jul;4(11):1391-4. doi: 10.4155/fmc.12.81. No abstract available.

PMID:
22857529
5.

Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas.

Golinska M, Troy H, Chung YL, McSheehy PM, Mayr M, Yin X, Ly L, Williams KJ, Airley RE, Harris AL, Latigo J, Perumal M, Aboagye EO, Perrett D, Stubbs M, Griffiths JR.

BMC Cancer. 2011 May 25;11:198. doi: 10.1186/1471-2407-11-198.

6.

Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays.

Airley R, Evans A, Mobasheri A, Hewitt SM.

Ann Anat. 2010 May 20;192(3):133-8. doi: 10.1016/j.aanat.2010.03.001. Epub 2010 Mar 24.

PMID:
20395120
7.

No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.

Charnley N, Airley R, Du Plessis D, West C, Brock C, Barnett C, Matthews J, Symonds K, Bottomly M, Swindell R, Price P.

Oncol Rep. 2008 Sep;20(3):537-42.

PMID:
18695903
8.
9.

Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.

Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung YL, Phillips R, Stubbs M, Griffiths J, Airley R.

Cancer Chemother Pharmacol. 2008 Mar;61(3):377-93. Epub 2007 May 23.

PMID:
17520257
12.
13.

Post-genomic applications of tissue microarrays: basic research, prognostic oncology, clinical genomics and drug discovery.

Mobasheri A, Airley R, Foster CS, Schulze-Tanzil G, Shakibaei M.

Histol Histopathol. 2004 Jan;19(1):325-35. doi: 10.14670/HH-19.325. Review.

PMID:
14702201
14.

Viral delivery of P450 reductase recapitulates the ability of constitutive overexpression of reductase enzymes to potentiate the activity of mitomycin C in human breast cancer xenografts.

Cowen RL, Patterson AV, Telfer BA, Airley RE, Hobbs S, Phillips RM, Jaffar M, Stratford IJ, Williams KJ.

Mol Cancer Ther. 2003 Sep;2(9):901-9.

15.

Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?

Cooper R, Sarioğlu S, Sökmen S, Füzün M, Küpelioğlu A, Valentine H, Görken IB, Airley R, West C.

Br J Cancer. 2003 Sep 1;89(5):870-6.

16.

GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.

Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CM, Stratford IJ.

Int J Cancer. 2003 Mar 10;104(1):85-91.

17.

Oxygen-sensitive enzyme-prodrug gene therapy for the eradication of radiation-resistant solid tumours.

Patterson AV, Williams KJ, Cowen RL, Jaffar M, Telfer BA, Saunders M, Airley R, Honess D, van der Kogel AJ, Wolf CR, Stratford IJ.

Gene Ther. 2002 Jul;9(14):946-54.

18.

A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis.

Williams KJ, Telfer BA, Airley RE, Peters HP, Sheridan MR, van der Kogel AJ, Harris AL, Stratford IJ.

Oncogene. 2002 Jan 10;21(2):282-90.

19.

Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, West C.

Clin Cancer Res. 2001 Apr;7(4):928-34.

Supplemental Content

Loading ...
Support Center